With countless opportunities on the Australian share market, pinpointing the best ASX growth stocks can be a challenge. However, certain companies stand out for their potential to generate substantial returns. If you’re looking to invest $2,000 into ASX growth shares this March, here are three top contenders that analysts believe could be prime picks.

Pro Medicus Limited (ASX: PME)

Pro Medicus has been a powerhouse in the health imaging technology space, consistently outperforming competitors with its cutting-edge Visage solution. The company’s rapid expansion is fueled by increasing demand from major medical institutions.

Analysts at Bell Potter remain bullish on Pro Medicus, citing its dominant position and strong pipeline of contracts. Recent developments include 10 new agreements in the past year, with further expansion anticipated in cardiology. With revenue projections for FY25 and FY26 seeing upward revisions, the outlook remains highly promising.

Analyst Verdict: Bell Potter maintains a buy rating with a price target of $330.00 per share.

ResMed Inc. (ASX: RMD)

ResMed is a global leader in sleep disorder treatment, offering innovative devices and software solutions for sleep apnoea and related conditions. With sleep apnoea affecting approximately 30% of men and 20% of women, the market potential for ResMed remains significant.

Goldman Sachs continues to back ResMed’s growth trajectory, noting that its strong patient demand and market leadership position will drive long-term success. Despite new weight-loss drugs entering the market, ResMed is well-positioned for continued expansion, particularly outside the U.S.

Analyst Verdict: Goldman Sachs has a conviction buy rating with a price target of $49.00 per share.

WiseTech Global Ltd (ASX: WTC)

WiseTech Global is a dominant player in the logistics software industry, with its CargoWise One platform being a key driver of operational efficiency for businesses worldwide. The company has demonstrated strong growth, with new product innovations set to fuel further expansion.

Despite facing some short-term setbacks, including leadership challenges and product delays, analysts remain confident in WiseTech’s long-term prospects. The company’s strategic focus on enhancing its software offerings and expanding global reach is expected to support sustained earnings growth.

Analyst Verdict: Bell Potter maintains a buy rating with a price target of $128.00 per share.

Unlock More Top ASX Stock Picks – Get Your Free Report!

If you’re looking for even more high-potential ASX stocks to invest in this March, we’ve got you covered! Our latest free report, ‘Top 5 ASX Stocks to Buy in FY25,’ reveals exclusive insights into the best investment opportunities right now.

✅ Expert stock recommendations
✅ In-depth market analysis
✅ Actionable insights for Australian investors

Claim your free report now: freereport.pristinegaze.com.au

Disclaimer:

Pristine Gaze Pty Ltd trading as Pristine Gaze (ABN 66 680 815 678) and (ACN 680 815 678) is a Corporate Authorised Representative (CAR No. 001312049) of Alpha Securities Pty Ltd (AFSL 330757). The information provided is general information only. Any advice is general advice only. No consideration has been given or will be given to individual objectives, financial situation, or specific needs of any particular person or organisation. The decision to engage our services and the method selected is a personal decision and involves inherent risks, and you must undertake your own investigations and obtain independent advice regarding suitability for your circumstances. Past performance, examples, or projections are not indicative of future results. While we strive to provide accurate information, we make no guarantees regarding the accuracy or completeness of our materials. The website may also contain links to third-party websites or resources, for which Pristine Gaze is not responsible. All content and intellectual property on the Pristine Gaze website, including but not limited to text, graphics, logos, and images, are the property of Pristine Gaze and are protected by applicable copyright and trademark laws. By accessing or using the Pristine Gaze website, you acknowledge and agree to the terms of this disclaimer. Please read our Terms and Conditions, Privacy Policy and Financial Service Guide for further information. Please read our Terms and Conditions, Privacy Policy and Financial Service Guide for further information.